ENDRA Life Sciences Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ENDRA Life Sciences Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • ENDRA Life Sciences Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $469K.
  • ENDRA Life Sciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7.52M, a 10.5% decline from 2022.
  • ENDRA Life Sciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8.4M, a 37.3% decline from 2021.
  • ENDRA Life Sciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $13.4M, a 12.9% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.52M -$881K -10.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $8.4M -$5M -37.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $13.4M +$1.53M +12.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $11.9M +$3.54M +42.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $8.34M -$337K -3.88% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $8.67M -$93.7K -1.07% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $8.77M +$7.32M +508% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-11
2016 $1.44M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.